Literature DB >> 22729282

ABVD vs. radiotherapy in early stage Hodgkin's lymphoma: A critical look at the NCIC HD.6 trial.

F Wenz, Y Abo-Madyan, G Welzel, F A Giordano.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22729282     DOI: 10.1007/s00066-012-0151-y

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  20 in total

1.  Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment.

Authors:  A J Swerdlow; J A Barber; G V Hudson; D Cunningham; R K Gupta; B W Hancock; A Horwich; T A Lister; D C Linch
Journal:  J Clin Oncol       Date:  2000-02       Impact factor: 44.544

2.  The radical radiotherapy of regionally localized Hodgkin's disease.

Authors:  H S KAPLAN
Journal:  Radiology       Date:  1962-04       Impact factor: 11.105

3.  Chemotherapy alone for early-stage Hodgkin's lymphoma.

Authors:  David J Straus
Journal:  N Engl J Med       Date:  2011-12-11       Impact factor: 91.245

Review 4.  Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors.

Authors:  Daphne de Jong
Journal:  J Clin Oncol       Date:  2005-09-10       Impact factor: 44.544

5.  Second malignancies in high‑dose areas of previous tumor radiotherapy.

Authors:  Birgitta Welte; Peter Suhr; Dirk Bottke; Detlef Bartkowiak; Wolfgang Dörr; Klaus Rüdiger Trott; Thomas Wiegel
Journal:  Strahlenther Onkol       Date:  2010-02-22       Impact factor: 3.621

6.  Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries.

Authors:  Amy Berrington de Gonzalez; Rochelle E Curtis; Stephen F Kry; Ethel Gilbert; Stephanie Lamart; Christine D Berg; Marilyn Stovall; Elaine Ron
Journal:  Lancet Oncol       Date:  2011-04       Impact factor: 41.316

7.  Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.

Authors:  Christophe Fermé; Houchingue Eghbali; Jacobus H Meerwaldt; Chantal Rieux; Jacques Bosq; Françoise Berger; Théodore Girinsky; Pauline Brice; Mars B van't Veer; Jan A Walewski; Pierre Lederlin; Umberto Tirelli; Patrice Carde; Eric Van den Neste; Emmanuel Gyan; Mathieu Monconduit; Marine Diviné; John M M Raemaekers; Gilles Salles; Evert M Noordijk; Geert-Jan Creemers; Jean Gabarre; Anton Hagenbeek; Oumédaly Reman; Michel Blanc; José Thomas; Brigitte Vié; Johanna C Kluin-Nelemans; Fernando Viseu; Joke W Baars; Philip Poortmans; Pieternella J Lugtenburg; Christian Carrie; Jérôme Jaubert; Michel Henry-Amar
Journal:  N Engl J Med       Date:  2007-11-08       Impact factor: 91.245

Review 8.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Authors:  James W Vardiman; Jüergen Thiele; Daniel A Arber; Richard D Brunning; Michael J Borowitz; Anna Porwit; Nancy Lee Harris; Michelle M Le Beau; Eva Hellström-Lindberg; Ayalew Tefferi; Clara D Bloomfield
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113

9.  Solid cancer incidence in atomic bomb survivors: 1958-1998.

Authors:  D L Preston; E Ron; S Tokuoka; S Funamoto; N Nishi; M Soda; K Mabuchi; K Kodama
Journal:  Radiat Res       Date:  2007-07       Impact factor: 2.841

Review 10.  Second tumors after oncologic treatment.

Authors:  Wolfgang Dörr; Thomas Herrmann
Journal:  Strahlenther Onkol       Date:  2008-02       Impact factor: 3.621

View more
  1 in total

1.  Omitting or reducing radiotherapy in childhood or adolescence Hodgkin Lymphoma.

Authors:  Theodoros P Vassilakopoulos; Georgios Boutsikas; Vassilios Papadakis
Journal:  Transl Pediatr       Date:  2013-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.